Swiss National Bank’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.57M | Buy |
70,200
+400
| +0.6% | +$20.4K | ﹤0.01% | 1465 |
|
2025
Q1 | $3.14M | Sell |
69,800
-500
| -0.7% | -$22.5K | ﹤0.01% | 1517 |
|
2024
Q4 | $2.91M | Buy |
70,300
+1,300
| +2% | +$53.8K | ﹤0.01% | 1642 |
|
2024
Q3 | $2.69M | Buy |
69,000
+4,200
| +6% | +$164K | ﹤0.01% | 1689 |
|
2024
Q2 | $2.22M | Buy |
64,800
+5,500
| +9% | +$188K | ﹤0.01% | 1752 |
|
2024
Q1 | $1.49M | Hold |
59,300
| – | – | ﹤0.01% | 1998 |
|
2023
Q4 | $1.75M | Buy |
59,300
+4,900
| +9% | +$145K | ﹤0.01% | 1925 |
|
2023
Q3 | $1.72M | Buy |
54,400
+700
| +1% | +$22.1K | ﹤0.01% | 1933 |
|
2023
Q2 | $1.39M | Buy |
53,700
+9,900
| +23% | +$256K | ﹤0.01% | 2127 |
|
2023
Q1 | $1.05M | Sell |
43,800
-4,300
| -9% | -$103K | ﹤0.01% | 2224 |
|
2022
Q4 | $938K | Buy |
48,100
+1,100
| +2% | +$21.5K | ﹤0.01% | 2379 |
|
2022
Q3 | $987K | Buy |
47,000
+9,600
| +26% | +$202K | ﹤0.01% | 2349 |
|
2022
Q2 | $728K | Buy |
+37,400
| New | +$728K | ﹤0.01% | 2509 |
|